Literature DB >> 25985365

The microRNA-200 family regulates pancreatic beta cell survival in type 2 diabetes.

Bengt-Frederik Belgardt1, Kashan Ahmed1, Martina Spranger1, Mathieu Latreille1, Remy Denzler1, Nadiia Kondratiuk1, Ferdinand von Meyenn1, Felipe Nunez Villena1, Karolin Herrmanns1, Domenico Bosco2, Julie Kerr-Conte3, Francois Pattou3, Thomas Rülicke4, Markus Stoffel1.   

Abstract

Pancreatic beta cell death is a hallmark of type 1 (T1D) and type 2 (T2D) diabetes, but the molecular mechanisms underlying this aspect of diabetic pathology are poorly understood. Here we report that expression of the microRNA (miR)-200 family is strongly induced in islets of diabetic mice and that beta cell-specific overexpression of miR-200 in mice is sufficient to induce beta cell apoptosis and lethal T2D. Conversely, mir-200 ablation in mice reduces beta cell apoptosis and ameliorates T2D. We show that miR-200 negatively regulates a conserved anti-apoptotic and stress-resistance network that includes the essential beta cell chaperone Dnajc3 (also known as p58IPK) and the caspase inhibitor Xiap. We also observed that mir-200 dosage positively controls activation of the tumor suppressor Trp53 and thereby creates a pro-apoptotic gene-expression signature found in islets of diabetic mice. Consequently, miR-200-induced T2D is suppressed by interfering with the signaling of Trp53 and Bax, a proapoptotic member of the B cell lymphoma 2 protein family. Our results reveal a crucial role for the miR-200 family in beta cell survival and the pathophysiology of diabetes.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25985365     DOI: 10.1038/nm.3862

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  63 in total

1.  Type 2 diabetes and congenital hyperinsulinism cause DNA double-strand breaks and p53 activity in β cells.

Authors:  Sharona Tornovsky-Babeay; Daniela Dadon; Oren Ziv; Elhanan Tzipilevich; Tehila Kadosh; Rachel Schyr-Ben Haroush; Ayat Hija; Miri Stolovich-Rain; Judith Furth-Lavi; Zvi Granot; Shay Porat; Louis H Philipson; Kevan C Herold; Tricia R Bhatti; Charles Stanley; Frances M Ashcroft; Peter In't Veld; Ann Saada; Mark A Magnuson; Benjamin Glaser; Yuval Dor
Journal:  Cell Metab       Date:  2013-12-12       Impact factor: 27.287

Review 2.  The endoplasmic reticulum stress response in the pancreatic β-cell.

Authors:  A Volchuk; D Ron
Journal:  Diabetes Obes Metab       Date:  2010-10       Impact factor: 6.577

3.  miR-29a and miR-29b contribute to pancreatic beta-cell-specific silencing of monocarboxylate transporter 1 (Mct1).

Authors:  Timothy J Pullen; Gabriela da Silva Xavier; Gavin Kelsey; Guy A Rutter
Journal:  Mol Cell Biol       Date:  2011-06-06       Impact factor: 4.272

4.  MyomiR-133 regulates brown fat differentiation through Prdm16.

Authors:  Mirko Trajkovski; Kashan Ahmed; Christine C Esau; Markus Stoffel
Journal:  Nat Cell Biol       Date:  2012-12       Impact factor: 28.824

5.  Dual-specificity phosphatase 26 is a novel p53 phosphatase and inhibits p53 tumor suppressor functions in human neuroblastoma.

Authors:  X Shang; S A Vasudevan; Y Yu; N Ge; A D Ludwig; C L Wesson; K Wang; S M Burlingame; Y-J Zhao; P H Rao; X Lu; H V Russell; M F Okcu; M J Hicks; J M Shohet; L A Donehower; J G Nuchtern; J Yang
Journal:  Oncogene       Date:  2010-06-21       Impact factor: 9.867

Review 6.  The biological functions of miRNAs: lessons from in vivo studies.

Authors:  Joana A Vidigal; Andrea Ventura
Journal:  Trends Cell Biol       Date:  2014-12-04       Impact factor: 20.808

7.  Pancreatic β cell dedifferentiation as a mechanism of diabetic β cell failure.

Authors:  Chutima Talchai; Shouhong Xuan; Hua V Lin; Lori Sussel; Domenico Accili
Journal:  Cell       Date:  2012-09-14       Impact factor: 41.582

8.  Death protein 5 and p53-upregulated modulator of apoptosis mediate the endoplasmic reticulum stress-mitochondrial dialog triggering lipotoxic rodent and human β-cell apoptosis.

Authors:  Daniel A Cunha; Mariana Igoillo-Esteve; Esteban N Gurzov; Carla M Germano; Najib Naamane; Ihsane Marhfour; Makiko Fukaya; Jean-Marie Vanderwinden; Conny Gysemans; Chantal Mathieu; Lorella Marselli; Piero Marchetti; Heather P Harding; David Ron; Décio L Eizirik; Miriam Cnop
Journal:  Diabetes       Date:  2012-07-06       Impact factor: 9.461

9.  Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization.

Authors:  Manav Korpal; Brian J Ell; Francesca M Buffa; Toni Ibrahim; Mario A Blanco; Toni Celià-Terrassa; Laura Mercatali; Zia Khan; Hani Goodarzi; Yuling Hua; Yong Wei; Guohong Hu; Benjamin A Garcia; Jiannis Ragoussis; Dino Amadori; Adrian L Harris; Yibin Kang
Journal:  Nat Med       Date:  2011-08-07       Impact factor: 53.440

Review 10.  β-cell failure in type 2 diabetes: postulated mechanisms and prospects for prevention and treatment.

Authors:  Philippe A Halban; Kenneth S Polonsky; Donald W Bowden; Meredith A Hawkins; Charlotte Ling; Kieren J Mather; Alvin C Powers; Christopher J Rhodes; Lori Sussel; Gordon C Weir
Journal:  Diabetes Care       Date:  2014-05-08       Impact factor: 19.112

View more
  101 in total

1.  miR-8 modulates cytoskeletal regulators to influence cell survival and epithelial organization in Drosophila wings.

Authors:  Kelsey Bolin; Nicholas Rachmaninoff; Kea Moncada; Katharine Pula; Jennifer Kennell; Laura Buttitta
Journal:  Dev Biol       Date:  2016-02-21       Impact factor: 3.582

2.  Preventing β-cell apoptosis and T2DM with microRNAs--a role for miR-200?

Authors:  Tim Geach
Journal:  Nat Rev Endocrinol       Date:  2015-06-02       Impact factor: 43.330

Review 3.  MicroRNAs as Potential Pharmaco-targets in Ischemia-Reperfusion Injury Compounded by Diabetes.

Authors:  Hassan Dehaini; Hussein Awada; Ahmed El-Yazbi; Fouad A Zouein; Khodr Issa; Assaad A Eid; Maryam Ibrahim; Adnan Badran; Elias Baydoun; Gianfranco Pintus; Ali H Eid
Journal:  Cells       Date:  2019-02-12       Impact factor: 6.600

Review 4.  Small molecules with big roles in microRNA chemical biology and microRNA-targeted therapeutics.

Authors:  Rengen Fan; Chaocheng Xiao; Xinqiang Wan; Wenzhang Cha; Yufeng Miao; Yong Zhou; Chenglin Qin; Ting Cui; Fenglian Su; Xiangxiang Shan
Journal:  RNA Biol       Date:  2019-04-03       Impact factor: 4.652

5.  Association of serum microRNAs with islet autoimmunity, disease progression and metabolic impairment in relatives at risk of type 1 diabetes.

Authors:  Isaac V Snowhite; Gloria Allende; Jay Sosenko; Ricardo L Pastori; Shari Messinger Cayetano; Alberto Pugliese
Journal:  Diabetologia       Date:  2017-05-12       Impact factor: 10.122

Review 6.  Role of miRNAs in the pathogenesis and susceptibility of diabetes mellitus.

Authors:  Naoko Hashimoto; Tomoaki Tanaka
Journal:  J Hum Genet       Date:  2016-12-08       Impact factor: 3.172

7.  Effects of the antagomiRs 15b and 200b on the altered healing pattern of diabetic mice.

Authors:  Gabriele Pizzino; Natasha Irrera; Federica Galfo; Giovanni Pallio; Federica Mannino; Angelica D'amore; Enrica Pellegrino; Antonio Ieni; Giuseppina T Russo; Marco Calapai; Domenica Altavilla; Francesco Squadrito; Alessandra Bitto
Journal:  Br J Pharmacol       Date:  2018-01-18       Impact factor: 8.739

Review 8.  Paracrine signaling in islet function and survival.

Authors:  Sean M Hartig; Aaron R Cox
Journal:  J Mol Med (Berl)       Date:  2020-02-17       Impact factor: 4.599

9.  Differential expression and release of exosomal miRNAs by human islets under inflammatory and hypoxic stress.

Authors:  Prathab Balaji Saravanan; Srividya Vasu; Gumpei Yoshimatsu; Carly M Darden; Xuan Wang; Jinghua Gu; Michael C Lawrence; Bashoo Naziruddin
Journal:  Diabetologia       Date:  2019-08-01       Impact factor: 10.122

Review 10.  The miRNA Interactome in Metabolic Homeostasis.

Authors:  Sean M Hartig; Mark P Hamilton; David A Bader; Sean E McGuire
Journal:  Trends Endocrinol Metab       Date:  2015-10-20       Impact factor: 12.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.